Skip to content

Rapid Micro Biosystems RPID Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-141.1%+36.9pp-178%+73.2pp-251.2%+118pp-369%-166pp
Net margin-140.3%+26.9pp-167.2%+65.8pp-233%+122pp-354.9%-38.4pp
Returns
Return on equity-86.8%-38.3pp-48.5%-11.3pp-37.2%-5.6pp-31.6%
Return on invested capital-93.7%-33.3pp-60.5%-14.4pp-46.1%
Efficiency
Asset turnover0.4×+0.2×0.2×+0.1×0.1×+0.1×0.1×-0.1×
Liquidity
Current ratio3.3×-1.3×4.6×-1.7×6.3×-0.9×7.3×-4.7×
Leverage
Debt-to-equity0.7×+0.6×0.1×0.0×0.1×0.0×
Per Share
Book value per share$0.74-57.0%$1.73-36.9%$2.74-29.1%$3.87-65.4%
Valuation
Market capitalization$86.19M-43.5%$38.73M+23.4%$31.38M-33.9%$47.45M-89.2%
Price / sales2.5×-2.5×1.4×0.0×1.4×-1.4×2.8×-16.2×
Price / book4.2×+1.4×0.5×+0.2×0.3×0.0×0.3×-1.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Rapid Micro Biosystems's ratios come from?
Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.